625. T Cell, NK Cell, or NK/T Cell Lymphomas: Clinical and Epidemiological: Poster II

Can the development of drug induced rash after mogamulizumab administration predict survival in mycosis fungoides sezary syndrome a trinetx based analysis

Enhanced clinical and systemic response with combination radiation therapy and topical imiquimod in mycosis fungoides A pilot study

Clinical significance of blood EBV DNA in peripheral T cell lymphoma not otherwise specified PTCL NOS and EBV positive nodal T cell lymphoma

Venetoclax based therapies in patients with Relapsed Refractory T cell prolymphocytic leukemia

Mitoxantrone hydrochloride liposome Lipo MIT combined with azacitidine and  Chidamide can be an effective chemotherapy regimen for patients with angioimmunoblastic T cell lymphoma AITL

Condensed total skin electron beam therapy prior to allogeneic stem cell transplantation in patients with cutaneous T cell lymphoma sezary syndrome

Golidocitinib combined with CHOP in treatment Naïve monomorphic epitheliotropic intestinal T cell lymphoma Preliminary results from A phase 2 multicenter single arm goal study

Preliminary efficacy and safety of golidocitinib in relapsed refractory T cell and NK cell large granular lymphocyte leukemia

First evaluation of novel cmoep Liposomal Mitoxantrone Based Chemotherapy in front line peripheral T cell lymphoma The compass Phase II study

Updated clinical data and biomarker analyses from the phase 1 study of DR 01 a non fucosylated anti CD94 antibody in patients with relapsed refractory cytotoxic lymphomas

Elevated interleukin 10 at diagnosis and during treatment independently predicts adverse outcomes in angioimmunoblastic T cell lymphoma

Heterogeneity of circulating CD57 cytotoxic cell subsets across disease stage and aggressiveness in cutaneous T cell lymphoma

A national analysis on ALK anaplastic large cell lymphomas Community based care linked to similar survival outcomes compared to academic centers

Frontline chemotherapy for CD30 non ALCL peripheral T cell lymphoma a multi center retrospective analysis

Combination of mitoxantrone hydrochloride liposome with chidamide in patients with relapsed or refractory peripheral T cell lymphoma Updated results of the phase II study

Facility level variation in hepatosplenic T cell lymphoma care Comparative outcomes from academic and community cancer centers

CHOP combined with linperlisib or chidamide may decrease the risk of mortality of monomorphic epitheliotropic intestinal T cell lymphoma A single center cohort study

Clinical features and outcomes of adult T cell leukemia lymphoma across world regions An international retrospective cohort study

Patterns of care in second line management of nodal peripheral T cell lymphoma from the lymphoma epidemiology of outcomes LEO and molecular epidemiology resource MER prospective cohort Study

BI 1808 a tumor necrosis factor receptor 2 TNFR2 blocker depleter showing promising efficacy in T cell lymphoma patients

Prognostic value of interim PET in patients with extranodal natural killer T cell lymphoma treated with non anthracycline containing l asparaginase based regimen